Results 91 to 100 of about 93,945 (299)
Advances in Radiotherapy for Neoadjuvant Therapy of Stage III Non-Small Cell Lung Cancer. [PDF]
This review summarizes three neoadjuvant radiotherapy techniques for stage III NSCLC, highlighting SFRT's low‐toxicity dual immune‐tumor control benefits and radioimmunotherapy's superior pathological response to guide precise multimodal treatment. ABSTRACT This review aims to systematically summarize the mechanisms of action, clinical evolution, and ...
Mao Q +5 more
europepmc +2 more sources
Treatment outcomes according to concurrent chemoradiotherapy duration.
Treatment outcomes according to concurrent chemoradiotherapy duration.
Ugur Selek (7022486) +6 more
core +1 more source
A Discharge Summary Prompt Reduces Postoperative Radiotherapy Delay in Head and Neck Cancer Patients
ABSTRACT Background Delays in postoperative radiotherapy (PORT) beyond 6 weeks are associated with worse outcomes in head and neck cancer (HNC). This study evaluated whether a discharge summary prompt could reduce PORT delay. Methods A retrospective review of patients from 2018 to 2023 was used as a pre‐intervention baseline.
Andreja Radevic +10 more
wiley +1 more source
Background Neoadjuvant chemoradiotherapy followed by surgery offers potential cure for locally advanced esophageal cancer. Yet, frailty often emerges post-therapy, heightening risks of delayed surgery and complications.
Chien-Hung Chiu +10 more
doaj +1 more source
Early Feasibility of Registration of Micro‐PET/CT Scans to Annotated 3D Specimen Models
ABSTRACT Background Intraoperative 18F‐fluorodeoxyglucose (18F‐FDG) micro‐positron emission tomography/computed tomography (micro‐PET/CT) is an emerging modality for margin assessment. Prior to clinical use, micro‐PET/CT margin distances must be correlated with gold‐standard histopathology.
Joaquin Austerlitz +13 more
wiley +1 more source
Purpose: Women with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy are at increased risk of venous thromboembolic events.
Ada Oele-Egelmeer +13 more
core +1 more source
Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer [PDF]
BackgroundDespite undergoing surgery and chemoradiotherapy, patients with first primary lung cancer (FPLC) remain at risk for second primary lung cancer (SPLC), which is associated with a poor prognosis.
Jiangjiang Liu +7 more
core +1 more source
ABSTRACT Background Frailty and sarcopenia may influence head and neck cancer (HNC) treatment outcomes, including dysphagia. Current understanding of this relationship, however, remains limited. This scoping review aimed to synthesize existing evidence on the relationship between frailty and/or sarcopenia and dysphagia in adults with HNC.
Rishni Perera +4 more
wiley +1 more source
ABSTRACT Introduction Head and neck cancer (HNC) survival is improving, increasing the need to address long‐term survivorship issues. Dental survivorship—care before, during, and after treatment—remains inconsistent across services. We conducted a review of systematic reviews and emerging evidence to inform contemporary dental survivorship care for HNC
David G. Tighe +3 more
wiley +1 more source

